The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...

The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

The drug fenfluramine has been recommended by the National Institute for Health and Care Excellence (NICE) for children with ...

NICE has approved another epilepsy treatment for Lennox–Gastaut syndrome. Fenfluramine can be used as an add-on to other ...

People with a rare form of epilepsy in England will now have a new treatment option to try following approval by NICE.

The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...

Starting today, the National Institute for Health and Care Excellence (NICE) has recommended the funding of fenfluramine for NHS patients in England. This new drug is specifically approved for ...

In a U-turn for the UK health technology assessor, the National Institute for Health and Care Excellence (NICE) has today ...

New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...